P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION WHO FAIL RITUXIMAB: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY

J. Sanz-Caballer, J. Storek, G. Socié, D. Thirumalai, N. Guzman-Beccera, P. Xun, D. Kumar, N. Sadetsky, D. Dierickx, J. Reitan, A. Barlev, M. Mohty

Open source

DOI: 10.1097/01.hs9.0000848220.74181.5a
Published: 6
Container: HemaSphere
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000848220.74181.5a,
  title = {P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION WHO FAIL RITUXIMAB: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY},
  author = {J. Sanz-Caballer and J. Storek and G. Socié and D. Thirumalai and N. Guzman-Beccera and P. Xun and D. Kumar and N. Sadetsky and D. Dierickx and J. Reitan and A. Barlev and M. Mohty},
  year = {2022},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000848220.74181.5a},
  url = {https://doi.org/10.1097/01.hs9.0000848220.74181.5a}
}

RIS

TY  - JOUR
TI  - P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION WHO FAIL RITUXIMAB: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY
AU  - J. Sanz-Caballer
AU  - J. Storek
AU  - G. Socié
AU  - D. Thirumalai
AU  - N. Guzman-Beccera
AU  - P. Xun
AU  - D. Kumar
AU  - N. Sadetsky
AU  - D. Dierickx
AU  - J. Reitan
AU  - A. Barlev
AU  - M. Mohty
PY  - 2022
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000848220.74181.5a
UR  - https://doi.org/10.1097/01.hs9.0000848220.74181.5a
ER  -

APA

Sanz-Caballer, J., Storek, J., Socié, G., Thirumalai, D., Guzman-Beccera, N., Xun, P., Kumar, D., Sadetsky, N., Dierickx, D., Reitan, J., Barlev, A., & Mohty, M. (2022). P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION WHO FAIL RITUXIMAB: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY. HemaSphere. https://doi.org/10.1097/01.hs9.0000848220.74181.5a

Source records

doaj · retrieved 2026-09-27T11:13:22.360Z